Savvy Trades and Investments

[swampboots]

Looked at TARA CABA and VINC,.same old story, each promising like 100's of others new avenues of promising patent protected strategies'. All good for science but not sure for shareholder ,as they need to plead their case to gullible philanthropic retail types ( like me) dreaming of discovering a new gem , starting with those stocks which have "open runways" (some cash) for another year. True no drug has ever been proven to fail ( no typo); so Co's can retro fit all studies with new trial change (uh, trial drug was not dosed enough, or at right time, or with wrong patient group, or with patients insufficiently given other drugs or conditions likely to make the primary drug work).

Got to remind myself to stay focused only on 3 conditions, massive insider buying , elite drug houses probing hard with shinny carrots, and platform scalable into billions focusing on unmet needs.